JPWO2020219908A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020219908A5 JPWO2020219908A5 JP2021563030A JP2021563030A JPWO2020219908A5 JP WO2020219908 A5 JPWO2020219908 A5 JP WO2020219908A5 JP 2021563030 A JP2021563030 A JP 2021563030A JP 2021563030 A JP2021563030 A JP 2021563030A JP WO2020219908 A5 JPWO2020219908 A5 JP WO2020219908A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- host cell
- sequence
- dna sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838498P | 2019-04-25 | 2019-04-25 | |
| US62/838,498 | 2019-04-25 | ||
| PCT/US2020/029855 WO2020219908A1 (fr) | 2019-04-25 | 2020-04-24 | Cas9 modifiée à plage de ciblage d'adn élargie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530055A JP2022530055A (ja) | 2022-06-27 |
| JPWO2020219908A5 true JPWO2020219908A5 (fr) | 2023-04-20 |
Family
ID=72941444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563030A Pending JP2022530055A (ja) | 2019-04-25 | 2020-04-24 | 拡張されたｄｎａ標的化範囲を有する操作されたｃａｓ９ |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220204954A1 (fr) |
| EP (1) | EP3958914A4 (fr) |
| JP (1) | JP2022530055A (fr) |
| KR (1) | KR20220025708A (fr) |
| CN (1) | CN114206394A (fr) |
| AU (1) | AU2020261071A1 (fr) |
| BR (1) | BR112021021306A2 (fr) |
| CA (1) | CA3137903A1 (fr) |
| IL (1) | IL287541A (fr) |
| MX (1) | MX2021012966A (fr) |
| SG (1) | SG11202111814XA (fr) |
| WO (1) | WO2020219908A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117866926A (zh) * | 2024-03-07 | 2024-04-12 | 珠海舒桐医疗科技有限公司 | 一种CRISPR-FrCas9蛋白突变体及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10202589B2 (en) * | 2015-03-03 | 2019-02-12 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases with altered PAM specificity |
| WO2016205759A1 (fr) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Modification et optimisation de systèmes, de méthodes, d'enzymes et d'échafaudages guides d'orthologues de cas9 et variant pour la manipulation de séquences |
| US9512446B1 (en) * | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| WO2018027078A1 (fr) * | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Éditeurs de nucléobases d'adénosine et utilisations associées |
| JP7456605B2 (ja) * | 2016-12-23 | 2024-03-27 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Ｐｃｓｋ９の遺伝子編集 |
| CN111201317B (zh) * | 2017-09-05 | 2024-04-05 | 国立大学法人东京大学 | 经修饰的Cas9蛋白及其用途 |
-
2020
- 2020-04-24 EP EP20796242.4A patent/EP3958914A4/fr not_active Withdrawn
- 2020-04-24 CN CN202080046596.2A patent/CN114206394A/zh active Pending
- 2020-04-24 BR BR112021021306A patent/BR112021021306A2/pt unknown
- 2020-04-24 JP JP2021563030A patent/JP2022530055A/ja active Pending
- 2020-04-24 AU AU2020261071A patent/AU2020261071A1/en active Pending
- 2020-04-24 US US17/605,932 patent/US20220204954A1/en active Pending
- 2020-04-24 KR KR1020217038012A patent/KR20220025708A/ko unknown
- 2020-04-24 MX MX2021012966A patent/MX2021012966A/es unknown
- 2020-04-24 CA CA3137903A patent/CA3137903A1/fr active Pending
- 2020-04-24 WO PCT/US2020/029855 patent/WO2020219908A1/fr unknown
- 2020-04-24 SG SG11202111814XA patent/SG11202111814XA/en unknown
-
2021
- 2021-10-24 IL IL287541A patent/IL287541A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11946040B2 (en) | Adenine DNA base editor variants with reduced off-target RNA editing | |
| JP2019536425A5 (fr) | ||
| JP7324713B2 (ja) | 改善された精度および特異性を有する塩基エディター | |
| JP6835726B2 (ja) | Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法 | |
| Karn et al. | Protein structural domains in the Caenorhabditis elegans unc-54 myosin heavy chain gene are not separated by introns. | |
| JP2022526695A (ja) | 遺伝子編集における非意図的な変異の阻害 | |
| JP2021166514A5 (fr) | ||
| CA3129158A1 (fr) | Editeurs de base adenosine desaminase et leurs methodes d'utilisation pour modifier une nucleobase dans une sequence cible | |
| JP2020534795A (ja) | ファージによって支援される連続的進化（ｐａｃｅ）を用いて塩基編集因子を進化させるための方法および組成物 | |
| JPWO2019236566A5 (fr) | ||
| WO2021042062A2 (fr) | Éditeurs combinatoires d'adénine et de cytosine à base d'adn | |
| CA3140093A1 (fr) | Procedes d'edition d'un polymorphisme mononucleotidique au moyen de systemes d'editeur de base programmables | |
| WO2020077138A2 (fr) | Variants d'éditeur de base d'adn pour la réduction sélective d'édition d'arn indésirable (secure) | |
| CA3228222A1 (fr) | Systemes crispr de classe ii, de type v | |
| JPWO2021050571A5 (fr) | ||
| US20190241911A1 (en) | Engineered guide rna and uses thereof | |
| JPWO2020219908A5 (fr) | ||
| JP2022533842A (ja) | 一塩基置換蛋白質およびそれを含む組成物 | |
| RU2021134280A (ru) | Сконструированный cas9 с расширенным диапазоном направленного воздействия на днк | |
| JP2024501892A (ja) | 新規の核酸誘導型ヌクレアーゼ | |
| Rutkai et al. | Analysis of insertion into secondary attachment sites by phage λ and by int mutants with altered recombination specificity | |
| KR20220025708A (ko) | 확장된 dna 표적 범위를 갖는 조작된 cas9 | |
| JPWO2020160514A5 (fr) | ||
| WO2022050413A1 (fr) | Complexe contenant une cytidine désaminase miniaturisé pour modifier l'adn double brin | |
| JPWO2021102390A5 (fr) |